HAEMONETICS CORP — Director's Dealing 2017

Apr 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-03-24

Reporting Person: GELBMAN RONALD G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-24	Common Stock	M	8580	$27.24	Acquired	58268	Direct
2017-03-24	Common Stock	S	8580	$40.00	Disposed	49688	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-24	Non-qualified Stock Option (Right to Buy)	$27.24	M	8580	Disposed	2017-07-29	Common Stock (8580)	Direct

Footnotes

F1: Cashless exercise and sale of net shares pursuant to a 10b5-1 trading plan.

F2: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.